Baroezet Tablet for High Cholesterol in Korean Adults
Part of Hormones & metabolism clinical trials.
This study tests how well and safely Baroezet Tablet works to lower cholesterol (dyslipidemia) in Korean patients. Researchers will follow people already taking this medication to see if it helps and track any side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 19 years old or older
- You have been diagnosed with high cholesterol or abnormal blood fats (dyslipidemia)
- Your doctor has recommended starting or continuing Baroezet Tablet for your condition
- You are not allergic to any ingredients in Baroezet Tablet
- You do not have active liver disease or liver problems
- You are not pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new combination pill for people with type 2 diabetes and high cholesterol who are already on metformin. It aims to see if the new drug helps control both blood sugar and cholesterol better than current treatments.
This trial tests a new drug called HS-10582 in healthy people and those with slightly high LDL cholesterol (a type of cholesterol). The goal is to see if it is safe and how well your body handles it.
This study tests a three-drug combination pill for high blood pressure in Korean adults. It aims to see if this treatment is safe and effective.
This trial tests a drug called bempedoic acid to see if it can safely help lower cholesterol in adults. It may be an option if you have high cholesterol and need a different treatment.
This study tests whether bempedoic acid, a new cholesterol-lowering medication, can help people with heart disease or very high cholesterol. You'd take it along with your current cholesterol medications to see if it further reduces your cholesterol levels and protects your heart.
This trial tests a new tablet called KPC000154 in healthy people to see if it is safe and how the body handles it. It may help develop a treatment for conditions related to high cholesterol.
Hear when a new Dyslipidemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.